| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |